Femasys (FEMY) Common Equity (2020 - 2026)
Femasys' (FEMY) quarterly Common Equity came in at $4.0 million in Q2 2026, up 167.4% on a YoY basis from $1.5 million in Q2 2025, and down 44.7% quarter-over-quarter from $7.3 million in Q1 2026.
Analysis
Femasys (FEMY) Common Equity (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Common Equity for 7 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity rose 167.4% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2026 stood at $4.0 million (up 167.4% YoY), and the FY2025 full-year result was $5.9 million, up 154.7% from the prior year.
- Common Equity retreated to $4.0 million in Q2 2026 per FEMY's latest filing, from $7.3 million in the prior quarter.
- Across five years, Common Equity topped out at $23.5 million in Q1 2022 and bottomed at $1.5 million in Q2 2025.
- Historically, Common Equity has averaged $10.7 million across 5 years, with a median of $10.8 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Common Equity sank 87.44% in 2024, then surged 265.09% in 2026.
- Over 5 years, Common Equity stood at $15.2 million in 2022, then grew by 20.4% to $18.4 million in 2023, then tumbled by 87.44% to $2.3 million in 2024, then surged by 154.7% to $5.9 million in 2025, then tumbled by 31.32% to $4.0 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $4.0 million, $7.3 million, and $5.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 18.30 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 50.85 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 23.99 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 25.17 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 10.72 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 21.60 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 2.62 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.03 Mn |
| Mar 31, 2026 | 7.29 Mn |
| Dec 31, 2025 | 5.87 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 5.97 Mn |
| Jun 30, 2024 | 11.25 Mn |
| Mar 31, 2024 | 15.61 Mn |
| Dec 31, 2023 | 18.35 Mn |
| Sep 30, 2023 | 10.44 Mn |
| Jun 30, 2023 | 12.88 Mn |
| Mar 31, 2023 | 12.36 Mn |
| Dec 31, 2022 | 15.24 Mn |
| Sep 30, 2022 | 18.01 Mn |
| Jun 30, 2022 | 20.94 Mn |
| Mar 31, 2022 | 23.49 Mn |
| Dec 31, 2021 | 26.33 Mn |
| Sep 30, 2021 | 28.65 Mn |